NRXP icon

NRX Pharmaceuticals
NRXP

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$37
1,402% upside
High target

4 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
D. Boral Capital
D. Boral Capital
Jason Kolbert
56% 1-yr NRXP win rate
3 Dec ‘25 yesterday
BTIG
BTIG
Thomas Shrader
100% 1-yr NRXP win rate
3 Dec ‘25 2 days ago
Ascendiant Capital
Ascendiant Capital
Edward Woo
50% 1-yr NRXP win rate
30 Oct ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Patrick Trucchio
33% 1-yr NRXP win rate
16 Oct ‘25 1 month ago